Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Humira
Pharma
AbbVie's Gonzalez collects $25.7M in his final full year as CEO
In his final full year as AbbVie’s CEO, Richard Gonzalez pulled down a compensation package worth $25.7 million, which was a slight decline from 2022.
Kevin Dunleavy
Mar 19, 2024 11:22am
Teva and Alvotech's Humira biosimilar finally snags FDA approval
Feb 23, 2024 9:00pm
After 11 years, AbbVie CEO Gonzalez set to retire on July 1
Feb 20, 2024 10:52am
AbbVie bets big on Rinvoq, Skyrizi as Humira succumbs to biosims
Feb 2, 2024 10:55am
With $25B haul, Merck's Keytruda looks to be top-selling drug
Feb 1, 2024 2:21pm
CVS to replace branded Humira with biosims on some formularies
Jan 4, 2024 11:38am